What Happens When Unicorns Exist, But Don’t Exit: How the Reverse-Acquihires Trend Threatens the Future of Innovation
When competition looms, incumbents often tighten their grip on a market by snapping up rivals and rapidly shelving breakthrough technologies that could otherwise accelerate the next wave of innovation. We now find ourselves at a similar technological inflection point where rapid innovation in AI poses a deep challenge to dominant firms.
To sidestep this challenge, large tech firms have adapted the acquihire—traditionally the acquisition of a company primarily for its talent rather than its products—into a structure that evades the regulatory scrutiny that would ordinarily accompany a merger of two companies. The result is the reverse-acquihire: unlike traditional acquihires these deals avoid antitrust scrutiny by replicating the benefits of an acquisition through alternative structures that stop short of an actual purchase. These deals allow dominant firms to both license a booming startup’s intellectual property and poach its top talent, often hollowing out the remaining company in the process.
The trend first emerged in 2024 and has since become a go-to strategy of incumbents wanting to maintain a competitive advantage, with growing implications for the long-term health of Silicon Valley’s innovation ecosystem. Over the last two years a majority of major American tech firms such as Google, Amazon, and Microsoft have turned to this workaround strategy.
Consolidation Across the AI Stack Harms Innovation
This consolidation is especially consequential because it spans the full AI stack—from cloud infrastructure and advanced chips to AI foundation models and the commercial software platforms that dominant firms already control and use to deploy AI at scale. As control over these layers becomes concentrated, costs rise and access becomes restricted, creating structural barriers for new entrants. Because each layer of the stack depends on the others, if even one piece of the AI innovation ecosystem gets locked up, it can stall the entire product innovation cycle.
In traditionally structured acquisitions, regulators would assess whether a transaction could limit access to critical inputs or otherwise constrain future innovation across the ecosystem in an anticompetitive manner. When these deals go unexamined by regulators, the result is less diverse technological solutions available on the market. Such limitations hinder scientific advancements in AI, reduce safety, and slow the responsible integration of the technology into broader economic and societal contexts.
These deals also pose a concern for other companies seeking to utilize core AI infrastructure services as part of their own product innovation practices. Meta’s 2025 reverse acquihire deal with Scale AI, a company that provides data annotation services necessary for the development of AI models, led to competitors such as Google and OpenAI ending their contracted data acquisition services with the company over concerns regarding their proprietary information being provided to Meta – a direct competitor company. Before the signing of the deal, Google had been Scale AI’s largest client. This deal perfectly illustrates how reverse acquihires can destabilize critical industry relationships, and cause detrimental impact across the entire ecosystem.
Reverse acquihires concentrate gains at the top, and weaken incentives for tech workers
The rapid emergence of the reverse-acquihire also risks breaking the unspoken social contract that powers Silicon Valley startups: top researchers and tech workers join startups for the chance at meaningful financial upside, autonomy, and accelerated growth, not just a salary. When startups opt for reverse acquihire deals, those key benefits become unevenly distributed.
Traditionally, joining a startup came with the expectation that all employees would share in the upside of a successful exit or acquisition. With a reverse-acquihire, however, investors and select staff benefit first, and remaining employees are usually left behind financially. This stands in stark contrast to the industry norm and undermines the financial incentive structure that draws talent to early-stage companies in the first place. Instead, knowledge and talent is funneled into the walled gardens of dominant firms while deepening inequality within the industry.
There is also a tangible labor market harm to tech workers. As these deals become more common, prospective hires must now assess not just the strength of a startup’s mission, but whether its founders will pursue a traditional, team-inclusive exit—or quietly cash out early. This added uncertainty deters risk-taking and creates a new class of winners and losers within the startup ecosystem, divided by who benefits from these lucrative deals and who gets left behind. The most sought-after AI researchers, scientists, and tech workers often choose startups for the chance at hyperprofitable exits. Remove that incentive, and they’ll opt for lower-risk roles at already dominant firms, thus reducing breakthrough product developments for us all.
This trend also impacts potential future founders in the ecosystem. Early hires who successfully exit a startup commonly use those earnings to bootstrap their own venture in the future. This dynamic famously played out across tech in the 2000s with the “PayPal mafia” diffusing both talent and capital in a manner that led to many successful tech companies being formed. Reverse acquihires could weaken this feedback loop.
Reverse Acquihires Could Break the VC Model
In addition to constraining future innovations and reducing the potential financial upside for startup employees, reverse-acquihire deals also threaten to destabilize the broader venture capital ecosystem. Typically, VC-backed companies favor acquisitions over IPOs, as they offer a faster, more predictable financial exit for investors, largely insulated from market volatility. Acquisitions also provide greater economic certainty and immediate liquidity, which can be especially appealing to venture capital firms. In contrast, IPOs are lengthy, complex processes that are highly sensitive to market conditions and external factors that can significantly impact valuations and, ultimately, equity holder and investor payouts.
If the reverse-acquihire trend continues, VC funds may increasingly lose the opportunity to invest in and fully realize financial returns from the next generation of unicorn AI companies. Without the outsized returns generated by mega-successful exits, the traditional venture capital model becomes difficult to sustain. As a result, the institutionalization of reverse acquihires across the tech industry could have a chilling effect on the flow of capital into smaller companies and startups that are creating the next big breakthrough. This trend is particularly harmful for AI innovation because the field is highly resource-intensive. Cutting-edge research conducted outside of dominant firms requires significant capital for datasets, cloud infrastructure, and specialized hardware, resources that startups typically access through venture capital.
Regulatory scrutiny is rising, but the risks extend beyond AI
With the Federal Trade Commission’s recent announcement of an investigation into these practices, questions about the evasion of antitrust laws will likely receive greater scrutiny. A member of the Commission has even publicly commented on the threats these deals pose to innovation. What remains largely absent, however, is a broader conversation about how the widespread use of these deals could reshape the full innovation ecosystem itself. While reverse-acquihire arrangements have so far been concentrated among AI-adjacent startups, their implications extend far beyond this sector. Similar structures could easily be deployed in other emerging fields, including biotechnology, where a reverse acquihire might prevent life-saving medical innovations from ever reaching the market.
When dominant firms consolidate technological talent and ideas solely for internal advantage, they do more than just preserve their competitive edge in a market. They also slow the pace of progress across the entire field. If reverse acquihires become the default path for absorbing promising startups, the dynamic competition that has long defined the American technology sector risks being replaced by a cycle of defensive consolidation that suppresses innovation to the detriment of our country as a whole.
By structuring licensing-and-talent deals that replicate mergers while avoiding antitrust scrutiny, dominant technology firms are reshaping AI labor markets, venture financing, and the future of U.S. innovation.
It is in the interests of the United States to appropriately protect information that needs to be protected while maintaining our participation in new discoveries to maintain our competitive advantage.
Our analysis of federal AI governance across administrations shows that divergent compliance procedures and uneven institutional capacity challenge the government’s ability to deploy AI in ways that uphold public trust.
To secure the U.S. bio-infrastructure, maintain global leadership in biotechnology, and safeguard American citizens from emerging threats to their privacy, the federal government must modernize its approach to human genetic and biological data.